Why Express Scripts Is Poised to Outperform (ESRX)

Why Express Scripts Is Poised to Outperform

Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, pharmacy benefit manager Express Scripts (NASDAQ: ESRX ) has earned a respected four-star ranking.

With that in mind, let's take a closer look at Express Scripts and see what CAPS investors are saying about the stock right now.

Express Scripts facts

Headquarters (founded)	St. Louis (1986)
Market Cap	$44.3 billion
Industry	Healthcare services
Trailing-12-Month Revenue	$78.9 billion
Management	Chairman/CEO George Paz CFO Jeffrey Hall
Return on Equity (average, past 3 years)	30.4%
Cash / Debt	$1.3 billion / $17.1 billion
Competitors	Catamaran (NASDAQ: CTRX ) CVS Caremark (NYSE: CVS )

Sources: S&P Capital IQ and Motley Fool CAPS.

On CAPS, 94% of the 795 members who have rated Express Scripts believe the stock will outperform the S&P 500 going forward.

Just last month, one of those Fools, mwlove, tapped the stock as a particularly attractive investment candidate:

[T]he synergies of the Medco merger are paying off handsomely, and Express Scripts will benefit from health care reform. The market has over-reacted to management talk of "overly aggressive" forecasts. Other than that [faux pas], management has been exemplary and will take the company forward to a very bright future.

Want a closer look at Express Scripts? In the Fool's brand new premium report on Express Scripts, Stock Advisor analyst Jim Mueller dives deep into the company's prospects. Here's a hint: There's plenty of room for growth. You'll understand why, along with an outline of the key must-watch areas of the company, if you claim a copy by clicking here now.

Want to see how well (or not so well) the stocks in this series are performing? Follow the TrackPoisedTo CAPS account.

Jeff Fischer and team have demystified options. And they can rack up income like $1,030... $2,626... and $3,228 on a schedule you can set your watch by!
That's why we're glad to announce every single one of their closely guarded strategies is available to YOU during May and June – 100% FREE, no strings attached! Just enter your email address in the box below...

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment icon found on every comment.